Mini‐review: Update on the genetics of schizophrenia

@article{Coelewij2018MinireviewUO,
  title={Mini‐review: Update on the genetics of schizophrenia},
  author={L. Coelewij and D. Curtis},
  journal={Annals of Human Genetics},
  year={2018},
  volume={82},
  pages={239 - 243}
}
A number of important findings have recently emerged relevant to identifying genetic risk factors for schizophrenia. Findings using common variants point towards gene sets of interest and also demonstrate an overlap with other psychiatric and nonpsychiatric disorders. Imputation of variants of the gene for complement component 4 (C4) from GWAS data has shown that the predicted expression of the C4A product is associated with schizophrenia risk. Very rare variants disrupting SETD1A, RBM12 or… Expand
Assessment of Potential Clinical Role for Exome Sequencing in Schizophrenia.
TLDR
The diagnostic yield from exome sequencing in schizophrenia is low and disruptive and damaging variants seen in known neuropsychiatric genes should not be automatically assumed to have an etiological role if observed in a patient with schizophrenia. Expand
A unique missense variant in the E1A-binding protein P400 gene is implicated in schizophrenia by whole-exome sequencing and mutant mouse models
TLDR
It is suggested that a missense variant in the E1A-binding protein P400 (EP400) gene is likely to cause schizophrenia in this Japanese family, and may lead to a better understanding and treatment of schizophrenia. Expand
In-silico investigation of coding variants potentially affecting the functioning of the glutamatergic N-methyl-D-aspartate receptor in schizophrenia
TLDR
The results are consistent with the hypothesis that ∼0.5% of patients with schizophrenia have disruptive or damaging genetic variants, which could plausibly impair functioning of NMDAR directly or indirectly through impairing Fyn function. Expand
Rare copy number variants in individuals at clinical high risk for psychosis: Enrichment of synaptic/brain‐related functional pathways
  • V. Jagannath, E. Grünblatt, +10 authors S. Walitza
  • Medicine
  • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2019
TLDR
Investigating the role of rare genome‐wide CNVs in clinical high risk for psychosis (CHR‐P) individuals suggested that rare CNVs might affect synaptic/brain‐related functional pathways in CHR‐P individuals. Expand
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms
TLDR
It is argued that NMDAR hypofunction occurs in early stage of the disease, and it may consequentially initiate GABA and dopamine deficits, therefore, targeting N MDAR dysfunction during the early stages would be a promising avenue for prevention and therapeutic intervention of cognitive and social deficits that remain untreatable. Expand
Neurodevelopmental concepts of schizophrenia in the genome-wide association era: AKT/mTOR signaling as a pathological mediator of genetic and environmental programming during development
TLDR
It is proposed that through convergence on AKT/mTOR signaling, these genes are critical factors directing both placentation and neurodevelopment, influencing risk for SCZ through dysregulation of placental function, metabolism and early brain development. Expand
Concordance of Immune-Related Markers in Lymphocytes and Prefrontal Cortex in Schizophrenia
TLDR
This work supports a role for immune dysfunction in the pathogenesis of schizophrenia and suggests that peripheral markers can be used as accessible surrogates to investigate putative central nervous system disruptions. Expand
Pursuing parity: genetic tests for psychiatric conditions in the UK National Health Service
Summary Schizophrenia and anorexia nervosa were recently added to the list of conditions for which whole genome sequencing might be indicated as part of the 100 000 Genomes Project, reflecting theExpand
Cross-Platform Validation of Neurotransmitter Release Impairments in Schizophrenia Patient-Derived NRXN1-Mutant Neurons
TLDR
It is shown that in neurons that were trans-differentiated from induced pluripotent stem cells derived from three NRXN1-deletion patients, the same impairment in neurotransmitter release was observed as in engineered NRXn1-deficient neurons. Expand
In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
TLDR
This review concerns the important issue of how cellular and animal systems can help to meet the challenges of modeling the disease, which fully manifests only in humans, as experimental studies of SZ in humans are limited. Expand
...
1
2
...

References

SHOWING 1-10 OF 34 REFERENCES
Loss-of-Function Variants in Schizophrenia Risk and SETD1A as a Candidate Susceptibility Gene
TLDR
Transmission pattern analyses reveal that LOF variants are more likely to be transmitted to affected individuals than controls, and especially true for private LOF variant in genes intolerant to functional genetic variation, which highlights the contribution of LOF mutations to the genetic architecture of schizophrenia. Expand
Recent genetic findings in schizophrenia and their therapeutic relevance
TLDR
This review summarises recent schizophrenia genetic findings and some key issues they raise, particularly with regard to their implications for identifying and validating novel drug targets. Expand
A polygenic burden of rare disruptive mutations in schizophrenia
TLDR
Analysis of exome sequences of schizophrenia cases and controls shows a polygenic burden primarily arising from rare, disruptive mutations distributed across many genes, suggesting that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease. Expand
Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia
  • G. Leonenko, A. Richards, +17 authors M. O’Donovan
  • Biology, Medicine
  • American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2017
TLDR
The genetic architecture of schizophrenia is delineated by excluding a role for uncommon exomic variants that confer a relatively large effect (odds ratio [OR] > 4) and it is shown risk alleles within this frequency range exist, but confer smaller effects and should be identified by larger studies. Expand
The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability
TLDR
It is shown that rare, damaging variants contribute to the risk of schizophrenia both with and without intellectual disability and support an overlap of genetic risk between schizophrenia and other neurodevelopmental disorders. Expand
Biological Insights From 108 Schizophrenia-Associated Genetic Loci
TLDR
Associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Expand
De novo mutations in schizophrenia implicate synaptic networks
TLDR
Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways, and pathophysiology shared with other neurodevelopmental disorders. Expand
Schizophrenia risk from complex variation of complement component 4
TLDR
It is found that many structurally diverse alleles of the complement component 4 (C4) genes generated widely varying levels of C4A and C4B expression in the brain, with each common C4 allele associating with schizophrenia in proportion to its tendency to generate greater expression of C 4A. Expand
Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders
TLDR
It is suggested that epigenetic dysregulation, specifically in the histone H3K4 methylation pathway, is an important mechanism in the pathogenesis of schizophrenia. Expand
The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review
TLDR
Overall, SZ-PRS was associated with increased risk for psychiatric disorders such as depression and bipolar disorder, lower performance IQ and negative symptoms, and a framework is proposed to guide robust reporting of PRS associations in the future. Expand
...
1
2
3
4
...